- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06869044
A Clinical Comparison of Proclear® 1 Day Multifocal and Clariti® 1 Day Multifocal 3 Add
April 9, 2026 updated by: CooperVision International Limited (CVIL)
A Clinical Comparison of Two Soft Multifocal Contact Lenses - Proclear® 1 Day Multifocal and Clariti® 1 Day Multifocal 3 Add
The aim of this study is to compare the overall lens satisfaction between two soft multifocal contact lenses.
Study Overview
Status
Completed
Conditions
Detailed Description
The aim of the study is to evaluate the overall lens satisfaction between two soft multifocal contact lenses when compared to each other after 15 minutes of daily wear each.
Study Type
Interventional
Enrollment (Actual)
67
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Berkeley, California, United States, 94720
- University of California, Berkeley, CA
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- They are at least 18 years of age.
- They understand their rights as a research subject and are willing and able to sign a Statement of Informed Consent.
- They habitually use soft contact lenses (multifocal soft contact lenses, sphere lenses for monovision, sphere lenses for distance vision correction and spectacles for near vision correction,) and have done so for at least the past three months.
- They have a minimum reading add of +0.75DS (based on their spectacle refraction)
- They have spherical equivalent refractive error between +6.00 to -10.00DS at the corneal plane and refractive astigmatism of no greater than -0.75DC in each eye.
- They are able to achieve distance HCVA of +0.10 logMAR or better in each eye.
Exclusion Criteria:
- They have an ocular disorder which would normally contra-indicate contact lens wear.
- They have a systemic disorder which would normally contra-indicate contact lens wear.
- They are aphakic.
- They have had corneal refractive surgery.
- They have any corneal distortion resulting from previous hard or rigid lens wear or have keratoconus.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: omafilcon A lenses first, then low ADD power somofilcon A lens
Participants will wear two different types of study contact lenses, in a randomized order of testing for the two study contact lens types.
|
Participants will be randomized to wear omafilcon A lens for 15 minutes.
Participants will be randomized to wear low ADD power somofilcon A lens for 15 minutes.
|
|
Experimental: omafilcon A lenses first, then medium ADD power somofilcon A lens
Participants will wear two different types of study contact lenses, in a randomized order of testing for the two study contact lens types.
|
Participants will be randomized to wear omafilcon A lens for 15 minutes.
Participants will be randomized to wear medium ADD power somofilcon A lens for 15 minutes.
|
|
Experimental: omafilcon A lenses first, then high ADD power somofilcon A lens
Participants will wear two different types of study contact lenses, in a randomized order of testing for the two study contact lens types.
|
Participants will be randomized to wear omafilcon A lens for 15 minutes.
Participants will be randomized to wear high ADD power somofilcon A lens for 15 minutes.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Overall lens satisfaction
Time Frame: At the end of 15 minutes wear
|
Overall Impression recorded on a visual analog scale of 0 to 100 where (0=Extremely poor.
Unmanageable.
Cannot use lenses, 100=Excellent.
Highly impressed with these lenses overall.)
|
At the end of 15 minutes wear
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Meng C Lin, OD, Ph.D, UC Berkeley
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 11, 2025
Primary Completion (Actual)
June 26, 2025
Study Completion (Actual)
June 26, 2025
Study Registration Dates
First Submitted
March 5, 2025
First Submitted That Met QC Criteria
March 5, 2025
First Posted (Actual)
March 11, 2025
Study Record Updates
Last Update Posted (Actual)
April 13, 2026
Last Update Submitted That Met QC Criteria
April 9, 2026
Last Verified
April 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- EX-MKTG-165
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Presbyopia
-
Ohio State UniversityRecruitingPresbyopia | Presbyopia CorrectionUnited States
-
Bruno Vision Careiuvo BioScience Operations, LLCCompleted
-
Johnson & Johnson Vision Care, Inc.CompletedPresbyopia CorrectionUnited Kingdom
-
VIS, Inc.Active, not recruitingPresbyopia Correction
-
AST Products, Inc.CompletedCataract | Presbyopia CorrectionSpain
-
IROC AGAMO IrelandActive, not recruitingCataract | Presbyopia CorrectionSwitzerland
-
Bausch & Lomb IncorporatedCompletedMyopia and Hyperopia and PresbyopiaUnited States
-
Technolas Perfect Vision GmbHUnknownHyperopic PresbyopiaIreland
-
The Hong Kong Polytechnic UniversityNot yet recruitingPresbyopia | Presbyopia Correction
-
University Eye Hospital SvjetlostCompletedCataract | Visual Acuity | Presbyopia CorrectionCroatia
Clinical Trials on omafilcon A lens
-
CooperVision, Inc.CompletedMyopiaUnited Kingdom
-
CooperVision, Inc.CompletedPresbyopia | AstigmatismUnited Kingdom
-
CooperVision, Inc.Centre for Ocular Research & Education, CanadaCompleted
-
CooperVision International Limited (CVIL)Centre for Ocular Research & Education, CanadaCompletedMyopia | AmetropiaCanada
-
CooperVision, Inc.Completed
-
CIBA VISIONCompleted
-
CIBA VISIONCompleted
-
CooperVision, Inc.Completed
-
CooperVision, Inc.Completed
-
CooperVision, Inc.CompletedPresbyopia | AstigmatismUnited Kingdom